CompoAtlas

必賜力牛磺酸膠囊

必賜力牛磺酸膠囊 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
TAURINETAURINETaurine
HYDROXYPROPYL METHYLCELLULOSEHYDROXYPROPYL METHYLCELLULOSENot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1046083986
Chinese name
必賜力牛磺酸膠囊
English name
BESTVITE TAURINE 1000MG
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
特德寶有限公司
Registration date
2016-03-14
Published validity end
2031-03-14

Original register data

View published fields and their variants
Product name
必賜力牛磺酸膠囊
Active ingredients
TAURINE;;HYDROXYPROPYL METHYLCELLULOSE;;
Valid until
1200314
Registration number
1046083986
Licence holder
特德寶有限公司
Registration date
1050314
Published reference
DHC0A460839861
Published English name
BESTVITE TAURINE 1000MG

Official source

View the official register, number 1046083986

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • TAURINE
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “必賜力牛磺酸膠囊”, https://compoatlas.com/en/supplements/taiwan/1046083986-bestvite-taurine-1000mg, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line